Authored by Chris Schroeder
Last month Bloomberg published an article detailing Merck’s all-out legal assault on generic drug maker Actavis over the threat of generic competition for its birth control blockbuster NuvaRing.
However, faced with the same threat of litigation from thousands of patients who reportedly suffered serious or fatal blood clots while using the birth control, the company has repeatedly denied NuvaRing’s risks or ignored the litigation altogether in reports to investors.
NuvaRing is a small, flexible contraceptive insert that has been used by millions of women since its launch in the U.S. in 2001. Analysts estimate it earned nearly $664 million for Merck in 2013.
Unfortunately, reports have linked it to increased risks of blood clots. The FDA has received thousands of reports of women suffering stroke, deep vein thrombosis or pulmonary embolism while using the device. However, they haven’t raised the possibility of a recall.
In 2012, a Dutch study found contraceptives like NuvaRing could lead to 6 times the risk of blood clot injuries.
So far, there is no class action lawsuit against NuvaRing. However, thousands of women have filed a NuvaRing lawsuit in federal or state courts and trials are scheduled to start this year.
In report after report, representatives of Merck continue to maintain that NuvaRing is safe and that patients were adequately warned of the risks. And, in their latest financial report, they don’t even mention the pending blood clot lawsuits specifically to investors.
Last month, the company filed suit against drug maker Actavis for even hinting that the company may release a generic version of NuvaRing when Merck’s current patent expires in 2018. Such a move indicates they may be far more concerned with profits than patients.
If you’ve asked, “Should I file a NuvaRing lawsuit?” it’s important to speak with a lawyer about your options. Lawyers continue to help those who’ve suffered a blood clot, stroke, DVT or pulmonary embolism file claims.
For the latest NuvaRing lawsuit update 2014, or to speak with a lawyer, contact us today. DrugRisk only recommends lawyers who have already handled NuvaRing lawsuits.